Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia.
Saved in:
| Title: | Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia. |
|---|---|
| Authors: | Engelmann R; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical School, Rostock, Germany., Flores-Montero J; Clinical and Translational Research Program, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.; Department of Medicine, Cytometry Service (NUCLEUS) and Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBER-ONC) (CB16/12/00400), Institudo de Salud Carlos III, Madrid, Spain., Schilperoord-Vermeulen J; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Ritgen M; Department of Internal Medicine II, University of Schleswig-Holstein, Kiel, Germany., Hengeveld PJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Kohlscheen S; Department of Internal Medicine II, University of Schleswig-Holstein, Kiel, Germany., Grigore G; Becton Dickinson R&D, Salamanca, Spain., Rodriguez RF; Becton Dickinson R&D, Salamanca, Spain., Lecrevisse Q; Clinical and Translational Research Program, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.; Department of Medicine, Cytometry Service (NUCLEUS) and Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBER-ONC) (CB16/12/00400), Institudo de Salud Carlos III, Madrid, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Philippé J; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Villamor N; Hematopathology Unit, Department of Pathology, Hospital Clínic of Barcelona, Barcelona, Spain., Fernandez P; FACS/Stem Cell Laboratory, Kantonsspital Aarau AG, Aarau, Switzerland., Burgos L; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC Number CB16/12/00369, Pamplona, Spain., van Dongen JJM; Department of Medicine, Cytometry Service (NUCLEUS) and Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; European Scientific Foundation for Laboratory Hemato-Oncology, Zutphen, the Netherlands., Orfao A; Clinical and Translational Research Program, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.; Department of Medicine, Cytometry Service (NUCLEUS) and Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBER-ONC) (CB16/12/00400), Institudo de Salud Carlos III, Madrid, Spain., Langerak AW; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Böttcher S; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical School, Rostock, Germany. |
| Corporate Authors: | EuroFlow Consortium |
| Source: | American journal of hematology [Am J Hematol] 2025 Apr; Vol. 100 (4), pp. 724-728. Date of Electronic Publication: 2025 Jan 25. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
